MEDANNEX LIMITED

Active Edinburgh

Research and experimental development on biotechnology

12 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
M

MEDANNEX LIMITED

Research and experimental development on biotechnology

Founded 28 Jul 2009 Active Edinburgh, United Kingdom 12 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Jun 2026 2 months remaining
Confirmation Submitted 11 Aug 2025 Next due 11 Aug 2026 3 months remaining
Net assets £969K £811K 2024 year on year
Total assets £1M £445K 2024 year on year
Total Liabilities £447K £1M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

1 Lochrin Square 92-98 Fountainbridge Edinburgh EH3 9QA United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for MEDANNEX LIMITED (SC363190), an active life sciences and medical technology company based in Edinburgh, United Kingdom. Incorporated 28 Jul 2009. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£293.26k

Decreased by £330.30k (-53%)

Net Assets

£969.46k

Increased by £810.83k (+511%)

Total Liabilities

£447.29k

Decreased by £1.26M (-74%)

Turnover

N/A

Employees

12

Decreased by 1 (-8%)

Debt Ratio

32%

Decreased by 59 (-65%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4
Grants 2

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Sept 2019Series B
Investor 2Sept 2019Series B

Share Capital

Share Capital

Share allotments and capital structure

31 Allotments 22,694,530 Shares £12.61m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 Jan 2026164,617£1.646£0
18 Dec 2025100,000£100£0.001
9 Dec 20251,305,000£13.05£0
3 Dec 2025923,198£459k£0.497
14 Nov 2025653,923£325k£0.497

Officers

Officers

1 active 2 resigned
Status
Christopher Barry WoodDirectorWelshUnited Kingdom8014 Jun 2010Active

Shareholders

Shareholders (88)

Morningside Venture Investments Limited
26.1%
11,111,111
Christopher Barry Wood
23.6%
10,040,764

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Professor Christopher Barry Wood

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB December 1945
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Adriel Wenbwo Chan

Ceased 11 Aug 2020

Ceased

Yuk Lan Wong

Ceased 11 Aug 2020

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
15 Jan 2026CapitalAllotment of shares (GBP 463.50844) on 2026-01-13
6 Jan 2026CapitalAllotment of shares (GBP 460.86227) on 2025-12-09
6 Jan 2026CapitalAllotment of shares (GBP 461.86227) on 2025-12-18
15 Dec 2025ResolutionResolutions
9 Dec 2025CapitalAllotment of shares (GBP 447.81227) on 2025-12-03
15 Jan 2026 Capital

Allotment of shares (GBP 463.50844) on 2026-01-13

6 Jan 2026 Capital

Allotment of shares (GBP 460.86227) on 2025-12-09

6 Jan 2026 Capital

Allotment of shares (GBP 461.86227) on 2025-12-18

15 Dec 2025 Resolution

Resolutions

9 Dec 2025 Capital

Allotment of shares (GBP 447.81227) on 2025-12-03

Recent Activity

Latest Activity

Allotment of shares (GBP 463.50844) on 2026-01-13

3 months ago on 15 Jan 2026

Allotment of shares (GBP 460.86227) on 2025-12-09

3 months ago on 6 Jan 2026

Allotment of shares (GBP 461.86227) on 2025-12-18

3 months ago on 6 Jan 2026

Resolutions

4 months ago on 15 Dec 2025

Allotment of shares (GBP 447.81227) on 2025-12-03

4 months ago on 9 Dec 2025